SCGB1A1 and lung disorder: The dysregulation of CC16 was often observed in the pathogenesis of pulmonary diseases, such as ARDS, asthma, COPD, etc. Functionally, CC16 has been demonstrated to provide anti-inflammatory and anti-oxidative effects in various cells [15,16].